InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
PennyStock Alert Free
09/17/19 11:43 AM
profile icon
north40000 PremiumMember
10/11/18 5:00 PM
profile icon
stocktrademan Free
02/11/18 11:55 AM
profile icon
Rogerthat1 Free
06/01/17 8:53 PM
profile icon
Frugivore Free
06/01/17 10:53 AM
profile icon
Frugivore Free
05/30/17 5:46 PM
profile icon
Frugivore Free
05/25/17 4:18 PM
profile icon
Frugivore Free
05/25/17 2:45 PM
profile icon
gregque Free
05/13/17 2:21 PM
profile icon
wiltonio Free
05/05/17 5:14 PM
profile icon
Cbdpotential Free
04/09/17 12:37 PM
profile icon
ClayTrader Free
02/15/17 5:06 PM
profile icon
guchu Free
02/03/17 9:12 AM
profile icon
stocktrademan Free
11/16/15 2:18 PM

Corium International Inc fka CORI RSS Feed

Followers
5
Posters
10
Posts (Today)
0
Posts (Total)
16
Created
11/16/15
Type
Free
Moderators
Corium International, Inc. 235 Constitution Drive Menlo Park, CA 94025 United States Phone: 650-298-8255 Fax: 650-298-8012 Website: http://www.coriumgroup.com Corium International, Inc., a biopharmaceutical company, focuses on the research, development, manufacture, and commercialization of specialty pharmaceutical products. Its products include Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for management of chronic pain, including cancer-related pain; Crest Whitestrips, a series of four products under the Advanced Vivid, Professional Effects, One Hour Express, and Flex-Fit brands for oral care. The company is also developing AG200-15, a combination hormonal contraceptive patch in Phase III clinical trials that delivers ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system, which has completed Phase I clinical trials for the treatment of severe osteoporosis; and Corplex Tamsulosin that has completed Phase I clinical trials for the treatment of benign prostatic hyperplasia. In addition, its products that have completed development, scale-up, and clinical activities include motion sickness patch for the prevention of nausea and vomiting associated with motion sickness; and urology patch for treatment of a urologic condition. Further, the company is developing Donepezil and Memantine transdermal patches for the treatment of Alzheimer's disease; and Ropinerole and Pramipexole therapies for the treatment of Parkinson's disease. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company, Teva Pharmaceuticals USA, Inc., Par Pharmaceutical, Inc., and Agile Therapeutics, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
Board Info
Posts Today
0
Posts (Total)
16
Posters
10
Moderators
New Post